(Q36895659)

16 August 2017

1 reference

title

Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection (English)

1 reference

16 August 2017

0 references

Pseudomonas aeruginosa

0 references

1 reference

John R W Govan

1

1 reference

PubMed ID

17661652

16 August 2017

Alan R Brown

series ordinal

2

1 reference

PubMed ID

17661652

16 August 2017

Andrew M Jones

series ordinal

3

1 reference

16 August 2017

1 April 2007

1 reference

16 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

16 August 2017

2

1 reference

16 August 2017

2

1 reference

16 August 2017

153-164

1 reference

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis

16 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Infection control in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Burkholderia cepacia: medical, taxonomic and ecological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Burkholderia cenocepacia sp. nov.--a new twist to an old story.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Cystic fibrosis: a polymicrobial infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

An epidemic Burkholderia cepacia complex strain identified in soil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Environmental Burkholderia cepacia complex isolates in human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Preventing Burkholderia cepacia complex infection in cystic fibrosis: is there a middle ground?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Burkholderia cepacia complex species: health hazards and biotechnological potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Pseudomonas serology: confusion, controversy, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Eradication of early Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Chronic melioidosis in a patient with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Growth in Stewart's medium is a simple, rapid and inexpensive screening tool for the identification of Burkholderia cepacia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.153

21 January 2018

Identifiers

DOI

10.2217/17460913.2.2.153

1 reference

16 August 2017

1 reference

PubMed ID

17661652